Join
Live feed
·
INSIDERFilingvia Quantisnow
Marinus Pharmaceuticals Inc. logo

Director Johnson Marvin returned $6,870 worth of shares to the company (12,490 units at $0.55), closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MRNS· Marinus Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MRNS (Marinus Pharmaceuticals Inc.) and more on Quantisnow.